Related Experiment Video
Updated: Mar 15, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Systems Medicine as an Emerging Tool for Cardiovascular Genetics
Tina Haase1, Daniela Börnigen1, Christian Müller1
1Clinic for General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany; Partner Site Hamburg/Kiel/Lübeck, German Center for Cardiovascular Research (DZHK e.V.), Hamburg, Germany.
Systems medicine offers novel approaches to understand complex cardiovascular diseases (CVD). This review explores bioinformatical and experimental tools for studying CVD pathogenesis and challenges in the field.
Area of Science:
- Cardiovascular research
- Systems medicine
- Genomics and molecular biology
Background:
- Cardiovascular disease (CVD) is a leading cause of global mortality.
- The underlying mechanisms of CVD are intricate and not fully understood.
- Systems medicine provides a holistic framework to investigate complex diseases.
Purpose of the Study:
- To review current systems medicine approaches for studying cardiovascular disease.
- To highlight the integration of computational and experimental methodologies.
- To discuss the application and challenges of systems medicine in CVD research.
Main Methods:
- Bioinformatical tools and analyses.
- Experimental models including cell and animal studies.
- Omics technologies (genomics, proteomics, metabolomics).
- Network and pathway analyses.
Main Results:
- Systems medicine integrates diverse data types to unravel CVD complexity.
- Successful applications of systems medicine in understanding CVD mechanisms are emerging.
- Identified challenges include data integration and model validation.
Conclusions:
- Systems medicine is a powerful paradigm for advancing cardiovascular disease research.
- Further development of tools and methodologies is crucial.
- This approach holds promise for novel diagnostic and therapeutic strategies in CVD.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pharmacogenomics: Identification of New Drug Targets
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

